Kennedy Schaal

Kennedy Schaal has a wide range of work experience in various industries. Starting in 2006, Schaal worked at Genescient Corporation as the Chief Biologist and Lab Director, where they were responsible for designing and conducting experiments, analyzing data, and preparing results for publication and presentation. In 2015, they also worked as an RYT-200 at Yoga Alliance. In 2022, Schaal held multiple roles including Spin-off CEO at SingularityNET, Chief Executive Officer at Rejuve.Bio, and Senior Biologist at Rejuve.AI.

Kennedy Schaal attended UC Irvine from 2003 to 2007, where they obtained a Bachelor's degree in Biological Sciences. During their time at UC Irvine, they focused on the field of Biology/Biological Sciences.